1. Introduction {#sec1}
===============

Lamellarins are a group of hexacyclic marine alkaloids that were initially isolated from a prosobranch mollusk by Faulkner and coworkers in 1985 \[[@B1]\]. Since then, over 70 compounds belonging to this group have been isolated and identified \[[@B2]\].

Some of these lamellarins and related compounds exhibit interesting biological activities in multidrug resistance (MDR) and their corresponding parental cell lines \[[@B3]\]. As well known \[[@B4]\], Lamellarin D (LMD) exhibits a significant cytotoxicity against a large panel of cancer cell lines and is a potential non-CPT (camptothecin) topoisomerase 1 poison \[[@B5], [@B6]\]. LMD affects cell cycle and acts on cancer cell mitochondria to induce apoptosia \[[@B7]\].

Due to the fascinating novel structures and biological activities, more and more researchers have devoted into the synthetic studies of lamellarins \[[@B8]\] and related 3,4-diarylpyrrolo derivatives. As one of the important alkaloids, 5,6-Dihydropyrrolo\[2,1-a\]isoquinolines exhibits pronounced biological activities. The biological activity of 5,6-dihydropyrrolo\[2,1-a\]isoquinolines **I** and **II** was evaluated by their effects on the proliferation of MDA-MB-231 (breast cancer cell line) by MTT assay. Our results showed that compound **I** could significantly inhibit the proliferation of MDA-MB-231 at the concentration of 40 *μ*g/mL, in contrast, compound **II** could enhance the proliferation of the MDA-MB-231 at the same concentration. In addition, they are also scaffolds for synthesis of lamellarin analogues \[[@B9]\].

Increasingly elegant synthetic routes have been developed. An efficient synthetic route for two compounds, 8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo\[2,1-a\]isoquinoline (**I**) and 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro\[2,1-a\]isoquinoline (**II**), is mainly introduced in this study. The synthetic procedure is very valuable because it employs 5,6-dihydropyrrolo\[2,1-a\]isoquinolines as starting materials and represents an easy and direct approach to a wide variety of 3,4-dihydroisoquinolines. The synthetic strategy is outlined in [Scheme 1](#sch1){ref-type="fig"}.

Isovanillin was protected with benzyl chloride to get 3-benzyloxy-4-methoxy-benzaldehyde (1) with 84.4% yield \[[@B10]\], which was condensed with nitromethane giving 2-benzyloxy-1-methoxy-4-(2-nitrovinyl)-benzene (2) with 80.5% yield \[[@B11]\]. Compound **2** was then reduced with LiAlH~4~ to get 2-(3-benzyloxy-4-methoxyphenyl)-vinylamine (3) with 84.9% yield \[[@B12]\]. Treatment of **3a\~b** with acetylchloride (n(**3a\~b**) : n(CH~3~COCl) : n(Et~3~N) = 1 : 1.8 : 4.0) afforded acetamide (**4a\~b**) with 81.9% and 90.7% yield, respectively, followed by cyclization with phosphorous oxychloride to get 3,4-dihydroisoquinoline **(5a\~b)** with 80.0% and 83.6% yield (n(**4a**) : n(POCl~3~) = 1 : 8). A solution of **5a\~b**, 2-bromo-1-(2,4,5-trimethoxy-phenyl)-ethanone and anhydrous K~2~CO~3~ in anhydrous acetonitrile was refluxed for 15 h. After a series of treatment, 5,6-dihydropyrrolo\[2,1-a\]isoquinoline **I** and **II** were obtained with 28.3% and 61.6% total yield, respectively.

2. Material and Methods {#sec2}
=======================

2.1. Analysis Means of Compounds {#sec2.1}
--------------------------------

Melting points (uncorrected) were determined by a Gongyi X-4 apparatus. Infrared spectra(IR) were determined by Nicolet 550 spectrometer. NMR spectra were recorded by Bruker DRX500 or Bruker DRX400 spectrometer. All data were calibrated at *δ* 0.00 ppm for ^1^H spectra and ^13^C spectra from the original spectra (TMS). Low resolution mass spectra (LRMS) were recorded with an HP 6890/5973 GC-MS mass spectrometer. High resolution mass (HRMS) for unreported compounds were recorded with a Micromass GTC Gas Chromatography/TOF Mass spectrometer. All solvent were redistilled prior to use, unless otherwise stated, all other commercially available chemicals were used without further purification.

2.2. Chemical Synthesis {#sec2.2}
-----------------------

### 2.2.1. 3-(benzyloxy)-4-methoxybenzaldehyde (1) {#sec2.2.1}

A mixture of isovanillin (10.0 g, 66 mmol), benzyl chloride (16 mL, 139 mmol), and anhydrous K~2~CO~3~ (6.5 g, 47 mmol) in EtOH (150 mL) was refluxed for 5 h. After being stirred, the reaction mixture was concentrated to dry and redissolved in 70 mL CH~2~Cl~2~, and then 5% aqueous NaOH (3 × 100 mL) was added. The organic layer was washed with brine (2 × 50 mL) and H~2~O (2 × 50 mL), dried with anhydrous Na~2~SO~4~, and evaporated to dryness. Needles were obtained after crystallization from MeOH/CH~2~Cl~2~ corresponding to 3-(benzyloxy)-4-methoxybenzaldehyde (15.0 g, 94%): m.p. 61\~62°C (lit.^13^ m.p. 61\~62°C); ^1^H NMR (400 MHz, CDCl~3~) *δ* 9.82 (s, 1H), 7.45\~7.47 (m, 4H), 7.38 (t, 2H, *J* = 7.34 Hz), 7.32 (t, 1H, *J* = 7.34 Hz), 6.99 (d, 1H, *J* = 8.24), 5.19 (s, 2H), 3.96 (s, 3H); MS (EI, 70 ev) m/z: 242(M^+^), 92, 91, 79, 77, 65, 63, 51.

### 2.2.2. (E)-2-(benzyloxy)-1-methoxy-4-(2-nitrovinyl)benzene (2) {#sec2.2.2}

A solution of compound **1** (10.0 g, 41 mmol), nitromethane (7 mL, 129 mmol) and NH~4~OAc (8.0 g, 104 mmol) in AcOH (125 mL) was refluxed for 4 h. After cooling, the mixture was diluted with H~2~O (100 mL) and extracted with CH~2~Cl~2~ (3 × 100 mL). The organic solution was washed with brine (2 × 100 mL) and H~2~O (2 × 100 mL), dried with anhydrous Na~2~SO~4~, and evaporated to dryness. Yellow needles were obtained from EtOH corresponding to (E)-2-(benzyloxy)-1-methoxy-4-(2-nitrovinyl)benzene (2) (9.6 g, 80.5%): m.p. 127\~128°C (lit.^14^ m.p. 125\~126°C)*；* ^1^H NMR (400 MHz, CDCl~3~) *δ* 7.91 (d, *J* = 13.6 Hz, 1H), 7.33\~7.46 (m, 6H) 7.18 (dd, *J* = 2.0, 8.36 Hz, 1H), 7.03 (d, *J* = 2.0 Hz, 1H), 6.93 (d, *J* = 8.36 Hz, 1H), 5.17 (s, 2H), 3.95 (s, 3H); MS (EI, 70 ev) m/z: 285 (M^+^), 92, 91, 77, 65, 63, 51.

### 2.2.3. 2-(3-(benzyloxy)-4-methoxyphenyl)ethanamine (3) {#sec2.2.3}

A solution of compound **2** (4.0 g, 14.0 mmol) in 14 mL of anhydrous THF was added dropwise to a well-stirred suspension of LiAlH~4~ (2.0 g, 52.8 mmol) in 50 mL of anhydrous THF and was refluxed for 6 h. After the solution was cooled, the excess reagent was destroyed by dropwise addition of EtOAc and 15% aqueous NaOH. After partial evaporation of the filtered portion, the aqueous solution was extracted with CH~2~Cl~2~ (3 × 30 mL), and the organic solution was washed with brine (2 × 20 mL) and H~2~O (2 × 20 mL), dried with anhydrous Na~2~SO~4~, and evaporated to dryness, and then 2-(3-(benzyloxy)-4-methoxyphenyl)ethanamine (3) (3.0 g, 84.9%) was obtained as an oil. ^1^H NMR (400 MHz, CDCl~3~) *δ* 6.73\~7.44 (m, 8H), 5.12 (s, 2H), 3.85 (s, 3H), 2.85 (t, *J* = 6.7 Hz, 2H), 2.62 (t, *J* = 6.7 Hz, 2H), 2.20 (br s, 2H); MS (EI, 70 ev) m/z: 257 (M^+^), 229, 228, 167, 137, 92, 91, 65.

### 2.2.4. N-(3-(benzyloxy)-4-methoxyphenethy)acetamide (4a) {#sec2.2.4}

A solution of 0.4 mL of acetyl chloride (5.6 mmol) in 5 mL anhydrous CH~2~Cl~2~ was added dropwise at 0°C to a solution of compound **3** (1.0 g, 3.88 mmol) and Et~3~N (1.7 mL, 12.26 mmol) in 20 mL anhydrous CH~2~Cl~2~, with stirring at 0°C for 2 h. After the mixture was stirred, 2.5% aqueous HCl was added and the organic solution was washed with brine (2 × 10 mL) and H~2~O (2 × 10 mL), dried with anhydrous Na~2~SO~4~, evaporated to dryness, and pale-yellow solid was obtained. Crude product was crystallized with EtOAc to afford *N*-(3-benzyloxy-4-methoxyphenylethyl)acetamide (0.94 g, 81.9%) as white crystals. m.p. 106\~108°C (lit.^15^ m.p. 122\~123°C); ^1^H NMR (400 MHz, CDCl~3~) *δ* 7.44 (d, *J* = 7.2 Hz, 2H), 7.36 (t, *J* = 7.2 Hz, 2H), 7.30 (d, *J* = 7.2 Hz, 1H), 6.84 (d, *J* = 8.8 Hz, 1H), 6.74 (d, *J* = 6.8 Hz, 2H), 5.14 (s, 2 H), 3.87 (s, 3H), 3.43 (q, *J* = 6.8, 12.8 Hz, 2H), 2.70 (t, *J* = 6.8 Hz, 2H), 1.88 (s, 3H).

### 2.2.5. 6-(benzyloxy)-7-methoxy-1-methyl-3,4-dihydroiso-quinoline (5a) {#sec2.2.5}

A solution of 0.9 mL of POCl~3~ (9.8 mmol) in 6 mL anhydrous CH~2~Cl~2~ was added dropwise at 40°C to a solution of compound **4a** (0.4 g, 1.06 mmol) in 10 mL anhydrous CH~2~Cl~2~, with stirring at 40°C for 3 h, then was poured into ice-water mixture, 2.5% aqueous NaOH was added to make pH about 12, the aqueous solution was extracted with CH~2~Cl~2~ (3 × 20 mL), and the organic solution was washed with brine (2 × 10 mL) and H~2~O (2 × 10 mL), dried with anhydrous Na~2~SO~4~, evaporated to dryness and solid was obtained. The crude product was purified with a silica gel column (Petroleum : EtOAc(v/v) = 3 : 1, 200\~300 H) to afford 6-(benzyloxy)-7-methoxy-1-methyl-3,4-dihydroisoquinoline (5a) (0.24 g, 80%) as brick red crystals. m.p. 95\~96°C; ^1^H NMR (500 MHz, CDCl~3~) *δ* 7.30\~7.44 (m, 5H), 7.01 (s, 1H), 6.7 (s, 1H), 5.17 (s, 2H), 3.90 (s, 3H), 3.61 (t, *J* = 7.2 Hz, 2H), 2.57 (m, *J* = 1.3, 7.5 Hz, 2H), 2.35 (t, *J* = 1.3 Hz, 3H).

### 2.2.6. 8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo\[2,1-a\]isoquinoline (I) {#sec2.2.6}

To a solution of 0.52 g compound 5a (1.85 mmol) in 15 mL anhydrous CH~3~CN was added 0.45 g 2-bromo-1-(2,4,5-trimethoxy-phenyl)-ethanone (1.85 mmol). The reaction mixture was stirred at 85°C for 10 h, then 0.38 g anhydrous K~2~CO~3~ (2.75 mmol) was added and continued to stir for another 10 h. After that the mixture was poured into 15 mL brine and extracted with CH~2~Cl~2~ (3 × 15 mL), the combined organic layers were dried with anhydrous Na~2~SO~4~, evaporated to dry, and brown oil was obtained. The crude product was purified with a silicagelcolumn (Petroleum : EtOAc(v/v) = 2 : 1, 200\~300 H) to afford 8-benzyl-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo\[2,1-a\]isoquinoline (I) (0.65 g, 74.7%) as offwhite sheet solid. m.p. 128°C; IR (KBr) **ν**: 2993, 2934, 2830, 1614, 1568, 1529, 1508, 1453,1427, 1365, 1336, 1274, 1166, 1130, 1035, 848, 810, 784, 738, 695 cm^−1^; ^1^H NMR (500MHz, CDCl~3~) *δ* 7.29--7.46 (m, 5H), 7.12 (d, *J* = 1.6 Hz, 1H), 7.11 (s, 1H), 7.10 (s, 1H), 6.73 (s, 1H), 6.69 (d, *J* = 1.6 Hz, 1H), 6.60 (s, 1H), 5.14 (s, 2H), 4.05 (t, *J* = 6.6 Hz, 2H), 3.94 (s, 3H), 3.91 (s, 3H), 3.91 (s, 3H), 3.88 (s, 3H), 2.95 (t, *J* = 6.6 Hz, 2H); ^13^C NMR (500 MHz, CDCl~3~) *δ*: 29.61, 44.91, 56.96, 56.97, 57.14, 57.43, 72.14, 99.34, 102.13, 107.32, 112.83, 115.18, 117.55, 120.83, 121.02, 123.60, 123.78, 128.03, 128.03, 128.50, 129.21, 129.21, 130.31, 137.98, 144.06, 147.25, 148.13, 149.82, 151.07; MS (LC-MS) m/z: 472 (M+1)^+^, 367, 318, 273; HRMS (ESI-Q-TOF) calcd for C~29~H~29~NO~5~ \[M+1\]^+^ 472.4856, found 472.4819.

### 2.2.7. N-(3,4-dimethoxyphenethyl)acetamide (4b) {#sec2.2.7}

A solution of 7.6 mL of acetyl chloride (0.11 mol) in 10 mL anhydrous CH~2~Cl~2~ was added dropwise at 0°C to a solution of compound **3b** (10 mL, 0.059 mol) and Et~3~N (32.8 mL, 0.23 mol) in 25 mL anhydrous CH~2~Cl~2~, with stirring at 0°C for 2 h. After the mixture was stirred, 2.5% aqueous HCl was added and the organic solution was washed with brine (2 × 30 mL) and H~2~O (2 × 20 mL), dried with anhydrous Na~2~SO~4~, evaporated to dryness, and yellow solid was obtained. Crude product was crystallized with EtOAc to afford N-(3,4-dimethoxyphenethyl) acetamide (4b) (11.8 g, 90.7%) as yellow crystals. m.p. 85\~86°C (lit.^16^ m.p. 94°C); IR (KBr) **ν**: 1642.54 cm^−1^ (--C=O), 3301.49 cm^−1^ (--NH--).

### 2.2.8. 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (5b) {#sec2.2.8}

A solution of 9.8 mL of POCl~3~ (0.1 mol) in 40 mL anhydrous CH~2~Cl~2~ was added dropwise at 40°C to a solution of compound **4b** (3.0 g, 13.4 mmol) in 30 mL anhydrous CH~2~Cl~2~, with stirring at 40°C for 3 h, then was poured into ice-water mixture; 2.5% aqueous NaOH was added to make pH about 12, the aqueous solution was extracted with CH~2~Cl~2~ (3 × 60 mL), and the organic solution was washed with brine (2 × 50 mL) and H~2~O (2 × 50 mL), dried with anhydrous Na~2~SO~4~, evaporated to dryness, and solid was obtained. The crude product was purified with a silica gel column (Petroleum : EtOAc(v/v) = 1 : 1, 200\~300 H) to afford 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (5b) (2.3 g, 83.6%) as brick red crystals. m.p. 98\~99°C (lit.^17^ m.p. 85\~96°C)*；* ^1^H NMR (500 MHz, CDCl~3~) *δ* 6.99 (s, 1H), 6.89 (s, 1H), 3.92 (s, 3H), 3.91 (s, 3H), 3.63 (m, *J* = 1.4, 7.5 Hz, 2H), 2.63 (t, *J* = 7.5 Hz, 2H), 2.36 (t, *J* = 1.4 Hz, 3H).

### 2.2.9. 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro\[2, 1-a\]isoquinoline (II) {#sec2.2.9}

To a solution of 1.5 g compound 5b (7.32 mmol) in 20 mL anhydrous CH~3~CN was added 1.78 g 2-bromo-1-(2,4,5-trimethoxy-phenyl)-ethanone (7.34 mmol). The reaction mixture was stirred at 85°C for 10 h, then 1.52 g anhydrous K~2~CO~3~ (11.0 mmol) was added and continued to stir for another 10 h. After that the mixture was poured into 30 mL brine and extracted with CH~2~Cl~2~ (3 × 30 mL), the combined organic layers were dried with anhydrous Na~2~SO~4~, evaporated to dryness, and brown oil was obtained. The crude product was purified with a silica gel column (Petroleum : EtOAc(v/v) = 2 : 1, 200\~300 H) to afford 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro\[2,1-a\]isoquinoline (II) (0.65 g, 72.6%) as gray solid. m.p. 137\~138°C; IR (KBr) **ν**: 2993, 2934, 2836, 1608, 1560, 1530, 1508, 1484, 1397, 1272, 1212, 1126, 1036, 808, 776 cm^−1^; ^1^H NMR (500 MHz, CDCl~3~) *δ*: 3.01 (t, *J* = 6.6 Hz, 2H), 3.87 (s, 3H), 3.88 (s, 3H), 3.91 (s, 3H), 3.92 (s, 3H), 3.95 (s, 3H), 4.07 (t, *J* = 6.6 Hz, 2H), 6.60 (s, 1H), 6.69 (d, *J* = 1.7 Hz, 1H), 6.70 (s, 1H), 7.08 (s, 1H), 7.12 (s, 1H), 7.13 (d, *J* = 1.7 Hz, 1H); ^13^C NMR (500 MHz, CDCl~3~) *δ*: 29.07, 44.28, 56.08, 56.15, 56.30, 56.49, 56.78, 98.68, 106.08, 101.36, 111.51, 112.19, 116.90, 120.12, 120.36, 122.43, 122.93, 129.70, 143.40, 147.38, 147.47, 148.38, 150.42; DEPT 135 (500 MHz, CDCl~3~) *δ*: two --CH~2~ (29.06, 44.28), five --CH~3~ (56.07, 56.14, 56.29,56.48,56.76), six --CH (98.62, 101.34, 106.05, 111.47, 112.15, 120.11); MS (LC-MS) m/z: 396 (M+1)^+^, 371, 276; HRMS (ESI-Q-TOF) calcd for C~23~H~25~NO~5~ \[M+1\]^+^ 396.4852, found 396.4884.

3. Results {#sec3}
==========

The target compounds **I** and **II** had been synthesized by our route and their structures were determined by interpretation of spectral data. The ^1^H NMR and ^13^C NMR spectra of them were assigned as indicated in Figures [1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [4](#fig4){ref-type="fig"}.

An initial ^1^H-NMR spectrum of **I** (in CDCl~3~) revealed four --OMe--H signals at 3.94 (s, 3H), 3.91 (s, 3H), 3.91 (s, 3H), 3.88 (s, 3H). These peaks are the featured signals of the --OMe--. 2.95 and 4.05 *doublets* (*J* = 6.6 Hz) indicate --CH~2~N-- and --CH~2~-- moieties connected with it in the isoquinoline ring. It can be seen that the distinguishing feature of Ar--CH~2~O 5.14 (s, 2H) is shown in [Figure 1](#fig1){ref-type="fig"}. There are several groups of signals in the aromatic region; they are 7.12 (d, *J* = 1.6 Hz, 1H), 7.11 (s, 1H), 7.10 (s, 1H), 6.73 (s, 1H), 6.69 (d, *J* = 1.6 Hz, 1H), and 6.60 (s, 1H), respectively. Among them, 7.12 (d, *J* = 1.6 Hz, 1H) and 6.69 (d, *J* = 1.6 Hz, 1H) are the signals in the pyrrole ring; this can be estimated from the peak type. Since Ar--H in the Ar--CH~2~O are influenced by other protons more slightly, they will overlap together and show the multiplet in the spectra. So 7.29--7.46 (m, 5H) is the signal of Ar--H in the Ar--CH~2~O. A molecular formula of C~29~H~29~NO~5~, resulted from HR-MS data of **I.** The ^13^C NMR spectrum of **I** displayed twenty-seven signals, which represented all twenty-nine C-atoms, eighteen of which were assignable to three aromatic-C moieties and accounted for sixteen spectral signals. Of the remaining eleven signals, four were from OMe (56.96, 56.97, 57.14, 57.43 ppm), and seven were from isoquinoline and pyrrole ring C-atoms.

NMR data of **II** (see Figures [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) indicated a C~23~H~25~ framework, which HR-MS analysis expanded to a molecular formula of C~23~H~25~NO~5~. The simplest assumed relationship between the two isoquinoline, **I** as an BnO-substituted **II**, was reinforced by characterization of the NMR data, which exhibited many similar signals. Specifically, too many shifts of H and C resonances are very similar to each other which proved the basic framework between **I** and **II**. The NMR signals which distinguished **I** from **II** were those of three aromatic protons appropriate for Ar--H (7.29--7.46 ppm, m, 5H) and --CH~2~-- in the Ar--CH~2~O. The remaining distinguishing feature was the number of --OMe-- signal in ^13^C NMR at 56-57 ppm.

4. Discussions {#sec4}
==============

**I** and **II** from 1-methyl-3,4-dihydroisoquinoline and 2,4,5-trimethoxy-*α*-halogen-acetophenone were obtained with high yields under mild conditions for the first time. This novel method, as the key reaction step, provides a general and highly efficient method for the preparation of 5,6-dihydropyrrolo\[2,1-a\]isoquinolines. We envisaged that the 5,6-dihydropyrrolo\[2,1-a\]isoquinolines could be constructed by the formation of quaternary ammonium salt, and subsequent lactonization in the presence of anhydrous K~2~CO~3~. The negative carbon ion of 1-methyl-3,4-dihydroisoquinoline is also active in the Knorr reaction. Both 2,4,5-trimethoxy-*α*-bromoacetophenone and 2,4,5-trimethoxy-*α*-chloracetophenone were employed. We found that the yield of the former is about 5% higher than the later. Therefore, 2,4,5-trimethoxy-*α*-bromoacetophenone is used in the synthesis of **I** and **II**.

5. Conclusion {#sec5}
=============

Based on the facile synthetic route depicted in [Scheme 1](#sch1){ref-type="fig"}, two novel scaffolds for synthesis of lamellarin analogues 8-benzyloxy-9-methoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydropyrrolo\[2,1-a\] isoquinoline (**I**) and 8,9-dimethoxy-2-(2,4,5-trimethoxyphenyl)-5,6-dihydro\[2,1-a\]isoquinoline (**II**) were obtained under mild condition. These two compounds are characterized by ^1^H NMR, ^13^C NMR, IR spectrum, and melting points. The products are stable and may be expected to exhibit biological activities to some extend.
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![Reagents and conditions: (i) BnCl, K~2~CO~3~, EtOH, reflux, 5 h, 94%; (ii) CH~3~NO~2~, NH~4~OAc, AcOH, reflux, 4 h, 80.5%; (iii) LiAlH~4~, THF, reflux, 6 h, 84.9%; (iv) CH~3~COCl, Et~3~N, CH~2~Cl~2~, 0°C, 2 h, 4a: 81.9%, 4b: 90.7%; (v) POCl~3~, CH~2~Cl~2~, reflux, 3 h, 5a: 80.0%, 5b: 83.6%; (vi) 2-halogen-1-(2,4,5-trimethoxyphenyl)ethanone, CH~3~CN, K~2~CO~3~, reflux, 20 h, I: 74.7%, II: 72.6%.](ECAM2011-103425.sch.001){#sch1}

![^1^H NMR spectrum of the **I**. Inserted figure is the magnification of the part of 7.00--7.50 of chemical shift.](ECAM2011-103425.001){#fig1}

![^13^C NMR spectrum of the **I**. Inserted figure is the magnification of the part of 120.00--135.00 of chemical shift.](ECAM2011-103425.002){#fig2}

![^1^H NMR spectrum of the **II**. Inserted figure is the magnification of the part of 7.00--7.20 of chemical shift.](ECAM2011-103425.003){#fig3}

![^13^C NMR spectrum of the **II**. Inserted figure is the magnification of the part of 110.00--130.00 of chemical shift.](ECAM2011-103425.004){#fig4}
